Science & Technology Partners’s Twist Bioscience TWST Stock Holding History

Science & Technology Partners’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.3M	Buy	+129,228	New	+$8.41M	2.24%	19

Other funds holding TWST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Science & Technology Partners's TWST Position: Q2 2026 in Review

Science & Technology Partners opened a new position in Twist Bioscience (TWST) in Q2 2026: 129,228 shares worth $13.3M. The stake represents 2.24% of the portfolio and ranks #19 among its holdings.

335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

Science & Technology Partners held 129,228 shares of Twist Bioscience worth $13.3M as of Q2 2026.
Twist Bioscience was a new Science & Technology Partners position in Q2 2026.
Twist Bioscience made up 2.24% of Science & Technology Partners's portfolio in Q2 2026, its #19 holding.
335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Science & Technology Partners's 13F filing for Q2 2026, filed 14 Aug 2026.